65710

Fix price-walking issue by end of 2021, UK tells insurers

Financial Conduct Authority revises timelines for general insurance reforms

65691

Covid-19 UK life claims in 2020 hit £202m

ABI members expect to pay up to £2.5bn, across all lines, in pandemic claims from last year

65650

Steven Findlay takes up Swiss Re CRO role

ABI's former head of prudential regulation returns to industry

65604

Change Solvency II to tackle climate change, insurers say

Direct Line outlines actions to address climate change

65602

"Pandemic Re" solutions may require mandatory purchase of cover

Barriers to creating a pandemic risk pool discussed at ABI's annual conference

65598

Matching adjustment becomes a battleground in UK's Solvency II consultation

Respondents to the UK's consultation on the future of Solvency II have taken starkly opposing positions on the matching adjustment, with some arguing for liberalisation and others for scrapping it. Christopher Cundy reports

65532

Bank of England ignites the debate on UK-EU Solvency II equivalence

The EU is in no rush to grant the UK reciprocal equivalence on Solvency II and has stirred anger by saying it wants to see how far the UK diverges before giving the green light. Paul Walsh assesses the state of play and whether there is any potential for a future agreement

65508

UK motor policyholders are due a £35 Covid-19 windfall, says consumer group

The Association of British Insurers stressed motorists were benefiting from a competitive motor insurance market

65491

Solvency II performed well during Covid-19, but challenges persist

Fitch event panellists discussed Solvency II, Covid-19 and post-pandemic recovery

65488

Genetic testing risks go under the microscope

Do life insurers really face the risk of adverse selection from customers that have taken predictive genetic tests? Academics think not, and insurers and policyholders could indeed benefit from wider use of genetic testing, as Paul Walsh reports